Brian Leyland-Jones: Now Is the Time!
“This is the transformative time in oncology,” heralds Brian Leyland-Jones, M.B., B.S., Ph.D., and there is no spin doctoring in the statement by the member of the National Foundation for Cancer Research’s scientific advisory board. From genomics to targeted therapies to vaccinations, the last 40 years has seen more strides…...
Zhen-Yi Wang & Zhu Chen: Quite a Combination
There was a time when if you were diagnosed with acute promyelocytic leukemia, or APL, the prognosis was grim. First discovered in 1957, APL is a form of acute myeloid leukemia, where immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a…...
Strategic Media Partner
